Hardened Hope: Care Advances for Fibrodysplasia Ossificans Progressiva

J Pediatr. 2021 May:232S:S1-S2. doi: 10.1016/j.jpeds.2021.02.035.

Authors

Peter Kannu¹, Charles E Levy²

Affiliations

¹ The Hospital for Sick Children and Peter Gilgan Centre for Research and Learning, Toronto, Ontario, Canada; University of Alberta, Toronto, Ontario, Canada. Electronic address: kannu@ualberta.ca.
² Center for Arts in Medicine, College of the Arts, University of Florida, Gainesville, FL.

PMID: 33896449
DOI: 10.1016/j.jpeds.2021.02.035

No abstract available

Publication types

Historical Article
Introductory Journal Article

MeSH terms

Activin Receptors, Type I / genetics
Diagnostic Errors
History, 18th Century
History, 19th Century
History, 20th Century
Humans
Myositis Ossificans / diagnosis
Myositis Ossificans / epidemiology*
Myositis Ossificans / genetics
Point Mutation
Rare Diseases

Substances

ACVR1 protein, human
Activin Receptors, Type I